CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 44 enrolled
Drug / intervention
sodium bicarbonate 500mg capsulesdrug
Likely dose
sodium bicarbonate 500mg capsulesfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02692378
NCT02692378Phase 4Completed
CompareCT.gov

A Feasibility Randomised Controlled Trial: Effects of Oral Sodium Bicarbonate Supplementation in Patients on Haemodialysis

Imperial College Healthcare NHS Trust·interventional·Posted Feb 26, 2016·Updated Oct 3, 2016

In Brief

A Phase 4 clinical trial evaluating sodium bicarbonate 500mg capsules for End-stage Renal Disease. Completed, enrolled 44 participants across 1 site.

Detailed Summary

The purpose of the study is to investigate whether oral sodium bicarbonate supplementation to ensure a constant bicarbonate profile in haemodialysis patients will primarily lower predialysis potassium levels and secondary lead to improvements in cardiac function, muscle mass and dialysis related symptoms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEnd-stage Renal Disease
CountriesUnited Kingdom
CollaboratorsNational Institute for Health Research, United Kingdom

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 26, 2016
Enrollment StartNov 1, 2015
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.3 years ago

Interventions

sodium bicarbonate 500mg capsulesdrug

Defined by active substance and brand names not specified in protocol